William Mezzanotte
Chief Tech/Sci/R&D Officer at CSL LIMITED
William Mezzanotte active positions
Companies | Position | Start | End |
---|---|---|---|
CSL LIMITED | Chief Tech/Sci/R&D Officer | 30/09/2018 | - |
Human Resources Officer | 30/09/2018 | - | |
University City Science Center
University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | Director/Board Member | 18/06/2020 | - |
Career history of William Mezzanotte
Former positions of William Mezzanotte
Companies | Position | Start | End |
---|---|---|---|
BELLUS HEALTH | Director/Board Member | 23/03/2021 | 31/12/2022 |
C.H. Boehringer Sohn AG & Co. KG
C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Corporate Officer/Principal | 31/03/2015 | 31/03/2017 |
ASTRAZENECA PLC | Corporate Officer/Principal | 31/05/2012 | 28/02/2015 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Chief Tech/Sci/R&D Officer | 31/03/2017 | - |
Corporate Officer/Principal | - | - |
Training of William Mezzanotte
Villanova University | Undergraduate Degree |
University of Pennsylvania | Doctorate Degree |
The Johns Hopkins University | Graduate Degree |
Statistics
International
United States | 6 |
United Kingdom | 2 |
Australia | 2 |
Operational
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 2 |
Sectoral
Health Technology | 6 |
Consumer Services | 4 |
Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
CSL LIMITED | Health Technology |
Private companies | 4 |
---|---|
C.H. Boehringer Sohn AG & Co. KG
C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
University City Science Center
University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | Miscellaneous |
BELLUS Health, Inc.
BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
- Stock Market
- Insiders
- William Mezzanotte
- Experience